| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
LeonaBio, Inc.
13D/A
LONA · 04746L203
|
25.1% |
10/28/2026
Event 10/26/2026
|
||||
| Sermonix Pharmaceuticals, Inc. | 25.1% | |||||
| Portman David J. | 25.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.